The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karras, J. G.
Right arrow Articles by Monia, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karras, J. G.
Right arrow Articles by Monia, B. P.
The Journal of Immunology, 2000, 164: 5409-5415.
Copyright © 2000 by The American Association of Immunologists

Inhibition of Antigen-Induced Eosinophilia and Late Phase Airway Hyperresponsiveness by an IL-5 Antisense Oligonucleotide in Mouse Models of Asthma

James G. Karras1,*, Kathy McGraw*, Robert A. McKay*, Scott R. Cooper{dagger}, Dmitri Lerner{dagger}, Tao Lu*, Christoph Walker{ddagger}, Nicholas M. Dean{dagger} and Brett P. Monia*

Departments of * Molecular and Cellular Pharmacology and {dagger} Pharmacology, Isis Pharmaceuticals, Carlsbad, CA 92008; and {ddagger} Novartis-Horsham Research Centre, Horsham, United Kingdom

Chronic airway eosinophilia is associated with allergic asthma and is mediated in part by secretion of IL-5 from allergen-specific Th2 lymphocytes. IL-5 is a known maturation and antiapoptotic factor for eosinophils and stimulates release of nascent eosinophils from bone marrow into the peripheral circulation. An antisense oligonucleotide found to specifically inhibit IL-5 expression in vitro was observed to significantly reduce experimentally induced eosinophilia in vivo, in both the murine OVA lung challenge and allergic peritonitis models. Intravenous administration resulted in sequence-dependent inhibition of eosinophilia coincident with reduction of IL-5 protein levels, supporting an antisense mechanism of action. Potent suppression of lung eosinophilia was observed up to 17 days after cessation of oligonucleotide dosing, indicating achievement of prolonged protection with this strategy. Furthermore, sequence-specific, antisense oligonucleotide-mediated inhibition of Ag-mediated late phase airway hyperresponsiveness was also observed. These data underscore the potential utility of an antisense approach targeting IL-5 for the treatment of asthma and eosinophilic diseases.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
R. S. Peebles Jr, K. Hashimoto, J. R. Sheller, M. L. Moore, J. D. Morrow, S. Ji, J. A. Elias, K. Goleniewska, J. O'Neal, D. B. Mitchell, et al.
Allergen-Induced Airway Hyperresponsiveness Mediated by Cyclooxygenase Inhibition Is Not Dependent on 5-Lipoxygenase or IL-5, but Is IL-13 Dependent
J. Immunol., December 15, 2005; 175(12): 8253 - 8259.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. C. Dorman, R. Sehmi, G. M. Gauvreau, R. M. Watson, R. Foley, G. L. Jones, J. A. Denburg, M. D. Inman, and P. M. O'Byrne
Kinetics of Bone Marrow Eosinophilopoiesis and Associated Cytokines after Allergen Inhalation
Am. J. Respir. Crit. Care Med., March 1, 2004; 169(5): 565 - 572.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. K. Farraj, J. R. Harkema, T.-R. Jan, and N. E. Kaminski
Immune Responses in the Lung and Local Lymph Node of A/J Mice to Intranasal Sensitization and Challenge with Adjuvant-Free Ovalbumin
Toxicol Pathol, June 1, 2003; 31(4): 432 - 447.
[Abstract] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
V. del Pozo, M. Rojo, M. L. Rubio, I. Cortegano, B. Cardaba, S. Gallardo, M. Ortega, E. Civantos, E. Lopez, C. Martin-Mosquero, et al.
Gene Therapy with Galectin-3 Inhibits Bronchial Obstruction and Inflammation in Antigen-challenged Rats through Interleukin-5 Gene Downregulation
Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 732 - 737.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. H. Mohamed, A. I. Abdelhamid, Y. C. G. Lee, K. B. Lane, B. Conner, M. Hawthorne, and R. W. Light
Pleural Fluid Levels of Interleukin-5 and Eosinophils Are Closely Correlated*
Chest, August 1, 2002; 122(2): 576 - 580.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Z. Allakhverdi, M. Allam, and P. M. Renzi
Inhibition of Antigen-induced Eosinophilia and Airway Hyperresponsiveness by Antisense Oligonucleotides Directed against the Common beta Chain of IL-3, IL-5, GM-CSF Receptors in a Rat Model of Allergic Asthma
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 1015 - 1021.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. M. Fleming, H. He, A. Ciota, D. Perkins, and P. W. Finn
Administration of Pentoxifylline During Allergen Sensitization Dissociates Pulmonary Allergic Inflammation from Airway Hyperresponsiveness
J. Immunol., August 1, 2001; 167(3): 1703 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.C. Kips, K.G. Tournoy, and R.A. Pauwels
New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5
Eur. Respir. J., March 1, 2001; 17(3): 499 - 506.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
E. Lach-Trifilieff, R. A. McKay, B. P. Monia, J. G. Karras, and C. Walker
In Vitro and In Vivo Inhibition of Interleukin (IL)-5-Mediated Eosinopoiesis by Murine IL-5R{alpha} Antisense Oligonucleotide
Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 116 - 122.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.